ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

UiPath Expands Healthcare Automation with New Global Professional Services Capabilities for Electronic Medical Records Platform

UiPath Platform™ enables faster access to a major EMR for customers and partners in 16 new global locations

UiPath (NYSE: PATH), a leading enterprise automation and AI software company, today announced that it has negotiated a new global consulting agreement with a major Electronic Medical Records (EMR) platform to accelerate professional services programs for customers in 16 new countries. With the agreement, UiPath significantly expands its professional services capabilities for healthcare organizations and makes customer and partner access to this EMR platform faster and more seamless.

EMRs are the backbone of modern healthcare, connecting patients, providers, and payers with vital information. While these platforms enhance the patient-provider experience, the overwhelming volume of work needed in the EMR means many healthcare providers spend more time with data than with patients, billing administrators are saddled with claims, and IT departments must orchestrate interoperability between services.

With the new agreement, customers and partners can now gain access in days rather than weeks, and UiPath can work more closely with strategic regional partners to provide customers with expanded options in talent and price point. New locations supported beyond the U.S. and Canada include Australia, France, Germany, Italy, Singapore, and Sweden, among others.

Automation and AI can help providers by reducing administrative and clinical abrasion, increasing revenue integrity, and lowering costs through optimizing interoperability and application testing.

“The EMR market for hospital systems alone is expected to grow beyond $20 billion in 2025, which shows the worldwide dependency on major EMR platforms for providers, payers, and patients. Unfortunately, healthcare costs also continue to rise in parallel. Automation and agentic automation are powerful solutions to lower costs and improve efficiencies,” said Jason Warrelmann, Vice President of Industry Practice at UiPath. “With professional services from UiPath and its qualified partners, healthcare organizations have significantly greater access and resources to drive down costs and automate more end-to-end processes with the ultimate goal of better care and more fulfilling work for healthcare professionals.”

Critically, as agentic automation and agentic AI grow in adoption, UiPath can help customers and partners scale their support for agentic solutions. Agentic automation enables software agents, powered by large language models (LLMs), generative AI (GenAI), and large action models (LAMs), as well as other advanced AI, to take autonomous action. Agentic automation agents can perceive their environment, reason and ask questions about it, and formulate and execute a set of actions to achieve specific goals.

People do not need to structure and direct these agents’ work; rather, agents themselves can assess data, recognize patterns, formulate new questions, draw conclusions, structure processes to get the work done, and execute the work.

Click here to discover how UiPath can drive agentic automation and other automation transformation in healthcare.

About UiPath

UiPath (NYSE: PATH) develops AI technology that mirrors human intelligence with ever-increasing sophistication, transforming how businesses operate, innovate, and compete. The UiPath Platform™ accelerates the shift toward a new era of agentic automation—one where agents, robots, people, and models integrate seamlessly to enable autonomous processes and smarter decision making. With a focus on security, accuracy, and resiliency, UiPath is committed to shaping a world where AI enhances human potential and revolutionizes industries. For more information, visit www.uipath.com.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.